Evommune EVMN
NYSE EVMN
$5.30 -0.09 (-1.58%)
As of: Oct 21, 2026 · 11:41 AM EDT

Evommune (EVMN) Retained Earnings (2024 - 2026)

Updated

Evommune's Retained Earnings came in at -$275.01 million for Q2 2026.

Analysis

Evommune (EVMN) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Retained Earnings was -$221.09 million.

  • Going back by year, Retained Earnings was -$152.22 million in FY2024.
  • Business Quant data shows EVMN's Retained Earnings at -$242.8 million (Q1 2026), -$221.09 million (Q4 2025) and -$192.82 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 171.67 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -17.33 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 12.59 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 2.20 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 112.09 Bn
10 Evommune 190.25 Mn -447.26 Mn - -275.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -275.01 Mn
Mar 31, 2026 -242.80 Mn
Dec 31, 2025 -221.09 Mn
Sep 30, 2025 -192.82 Mn
Dec 31, 2024 -152.22 Mn
API Access

Evommune Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=EVMN&period=max&api_key=YOUR_API_KEY